Effectiveness of Oral Acyclovir in Treatment of Infectious Mononucleosis in Childre

Phase 3

• Conditions: Infectious Mononucleosis.; Cytomegaloviral mononucleosis, without complications; B27.10

• Registration Number: IRCT20201201049554N1
• Lead Sponsor: Gorgan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

Children (1 to 16 years old) who have symptoms of the disease including sore throat, lymphadenopathy and fatigue
Symptoms begin within the last 3 days
fever 38 c

Exclusion Criteria

No need for hospitalization
Underlying diseases such as diabetes and asthma
Antiviral and steroid treatment for the past 2 weeks
serum creatinine higher than 1.6

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Reduce the hospitalization duration. Timepoint: The patient's general condition and the presence of respiratory distress will be assessed daily after starting treatment. Method of measurement: Medical assessment and physical examination.;Reduce severity of disease. Timepoint: The presence of fever, exudative sore throat, respiratory distress, stridor is evaluated daily after starting treatment. Method of measurement: Medical assessment and physical examination.